Aktis Oncology Inc <AKTS.O>: Wedbush initiates coverage with outperform rating; target price $35
AKTS•Related News
Vibe coding is a low-key threat to software firms
WDAY•
Stock Yards Bancorp raises quarterly cash dividend to $0.33 a share
SYBT•
Gold.com sets fiscal Q4, full-year 2026 earnings call
GOLD•
Core Natural Resources Advances Its Executive Succession Plan
CNR•
Dole to join Barclays Global Consumer Conference
DOLE•